High grade osteosarcoma of the extremities with lung metastases at presentation: Treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions
Abstract
Background and Methods: Between 1986 and 2001, 162 patients with extremity osteosarcoma and lung metastases at presentation, were treated by neoadjuvant chemotherapy, simultaneous resection of primary and, when feasible, secondary lesions followed by chemotherapy. Results: After neoadjuvant chemotherapy, metastases disappeared in 14 patients, 16 were judged unresectable by both our thoracic surgeons, 132 had primary tumors and lung metastases removed simultaneously. Removal of lung metastases was complete in 123 and incomplete in 9. Histologically lesions were benign in 32 patients. For the 100 patients simultaneously operated with histologically proven lung metastases, 5‐year event‐free survival (EFS) was 18.9%; 27.4% for the 91 who had a complete resection of pulmonary lesions and entered remission as opposed to none for 9 patients who had incomplete removal of lung nodules. Among these 91, 5‐year EFS was significantly higher for patients with monolateral compared to bilateral lesions (27.1% vs. 7.9%, P < 0.02) and when only one to three metastatic nodules were present (40.0% vs. 13.3%, P < 0.0001). Conclusions: These different results, demonstrate that our treatment had a reasonable survival outcome whereas other groups continue to have dismal prognosis. More efforts should be made to improve survival by identifying new active agents or novel approaches with cellular molecular targets. J. Surg. Oncol. © 2008 Wiley‐Liss, Inc.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Osteosarcoma is a tumor with a high tendency for metastasis, and 15-20% of newly diagnosed osteosarcoma are detected with metastasis.
“osteosarcoma is a tumor with a high tendency for metastasis, and 15-20% of newly diagnosed osteosarcoma are detected with metastasis [7].”
From Advances on immunotherapy for osteosarcoma (2024) · cites this paper as [7]
Cites
Kager, L., Zoubek, A., Pötschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.132 · Cited by 934 · see citing works
Metastasis: recent discoveries and novel treatment strategies.
Eccles, S., & Welch, D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60781-8 · Cited by 729 · see citing works
Primary bone osteosarcoma in the pediatric age: State of the art
Longhi, A., Errani, C., PAOLIS, M. D., Mercuri, M., & Bacci, G. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.05.005 · Cited by 630 · see citing works
Self-citationPrognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy
Bacci, G., Longhi, A., Versari, M., Mercuri, M., Briccoli, A., & Picci, P. (2006) · Cancer · doi:10.1002/cncr.21724 · Cited by 567 · see citing works
Self-citationFerrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., Alvegård, T. A., Picci, P., Capanna, R., Bernini, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5785 · Cited by 432 · see citing works
Self-citationOsteogenic sarcoma with clinically detectable metastasis at initial presentation.
Meyers, P. A., Heller, G., Healey, J. H., Huvos, A. G., Applewhite, A., Sun, M., & LaQuaglia, M. P. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.449 · Cited by 389 · see citing works
Metastatic osteosarcoma at diagnosis
Mialou, V., Philip, T. O., Kalifa, C., Pérol, D., Gentet, J., Marec‐Bérard, P., Pacquement, H., Chastagner, P. B., Defaschelles, A.-S., & Hartmann, O. (2005) · Cancer · doi:10.1002/cncr.21263 · Cited by 283 · see citing works
Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma
Inoue, K., Ozeki, Y., Suganuma, T., Sugiura, Y., & Tanaka, S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970115)79:2 · Cited by 254 · see citing works
Self-citationGoorin, A. M., Harris, M. B., Bernstein, M. L., Ferguson, W., Devidas, M., Siegal, G. P., Gebhardt, M. C., Schwartz, C. L., Link, M. P., & Grier, H. E. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.426 · Cited by 223 · see citing works
Kaste, S. C., Pratt, C. B., Cain, A. M., Jones-Wallace, D., & Rao, B. N. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991015)86:8 · Cited by 212 · see citing works
Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study.
Harris, M. B., Gieser, P. W., Goorin, A. M., Ayala, A. G., Shochat, S. J., Ferguson, W. S., Holbrook, T., & Link, M. P. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3641 · Cited by 185 · see citing works
Davis, S., Wright, P. W., Schulman, S. F., Hill, L. D., Pinkham, R. D., Johnson, L. P., Jones, T. W., Kellogg, H. B., Radke, H., Sikkema, W. W., et al. (1985) · Cancer · doi:10.1002/1097-0142(19851001)56:7 · Cited by 154 · see citing works
Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis
Marina, N. M., Pratt, C. B., Rao, B. N., Shema, S. J., & Meyer, W. H. (1992) · Cancer · doi:10.1002/1097-0142(19921201)70:11 · Cited by 116 · see citing works
Daw, N. C., Billups, C. A., Galindo, C. R., McCarville, M. B., Rao, B. N., Cain, A. M., Jenkins, J. J., Neel, M. D., & Meyer, W. H. (2005) · Cancer · doi:10.1002/cncr.21626 · Cited by 112 · see citing works
Bacci, G., Mercuri, M., Briccoli, A., Ferrari, S., Bertoni, F., Donati, D. M., Monti, C., Zanoni, A., Forni, C., & Manfrini, M. (1997) · PubMed · Cited by 109 · see citing works
Self-citationFerguson, W. S., Harris, M. B., Goorin, A. M., Gebhardt, M. C., Link, M. P., Shochat, S. J., Siegal, G. P., Devidas, M., & Grier, H. E. (2001) · The American journal of pediatric hematology/oncology · doi:10.1097/00043426-200108000-00004 · Cited by 72 · see citing works
Results of Treatment for Metastatic Osteosarcoma With Neoadjuvant Chemotherapy and Surgery
Thompson, R. C., Cheng, E. Y., Clohisy, D. R., Perentesis, J. P., Manivel, C. J., & Le, C. T. (2002) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200204000-00028 · Cited by 62 · see citing works
Bacci, G., Briccoli, A., Ferrari, S., Sæter, G., Donati, D. M., Longhi, A., Manfrini, M., Bertoni, F., Rimondini, S., Monti, C., et al. (2000) · Oncology Reports · doi:10.3892/or.7.2.339 · Cited by 54 · see citing works
Self-citationNachman, J. B., Simon, M., Dean, L., Shermeta, D. W., Dawson, P. M., & Vogelzang, N. J. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.8.1185 · Cited by 35 · see citing works
Pacquement, H., Kahfa, C., Fagnou, C., Demaille, M. C., Brunat-Mentigny, M., Sariban, E., Pérel, Y., & Zucker, J. M. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)85082-4 · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Osteosarcoma treatment – Where do we stand? A state of the art review
Lütke, A., Meyers, P. A., Lewis, I. J., & Juergens, H. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.006 · Cited by 1,237 · see citing works
Smeland, S., Bielack, S. S., Whelan, J., Bernstein, M., Hogendoorn, P., Krailo, M. D., Gorlick, R., Janeway, K. A., Ingleby, F. C., Anninga, J., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2018.11.027 · Cited by 704 · see citing works
Review of Osteosarcoma and Current Management
Durfee, R. A., Mohammed, M., & Luu, H. H. (2016) · Rheumatology and Therapy · doi:10.1007/s40744-016-0046-y · Cited by 397 · see citing works
Metastatic osteosarcoma: a challenging multidisciplinary treatment
Meazza, C., & Scanagatta, P. (2016) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2016.1168697 · Cited by 300 · see citing works
Simpson, S., Dunning, M., de Brot, S., Grau‐Roma, L., Mongan, N. P., & Rutland, C. S. (2017) · Acta veterinaria Scandinavica · doi:10.1186/s13028-017-0341-9 · Cited by 294 · see citing works
Advances on immunotherapy for osteosarcoma
Yu, S., & Yao, X. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02105-9 · Cited by 270 · see citing works
Messerschmitt, P. J., Garcia, R., Abdul‐Karim, F. W., Greenfield, E. M., & Getty, P. J. (2009) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/00124635-200908000-00005 · Cited by 266 · see citing works
Systemic cancer therapy: achievements and challenges that lie ahead
Palumbo, M. O., Kavan, P., Miller, W. H., Panasci, L., Assouline, S. E., Johnson, N., Cohen, V., Patenaude, F., Pollak, M., Jagoe, R. T., et al. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00057 · Cited by 240 · see citing works
Eaton, B. R., Schwarz, R., Vatner, R. E., Yeh, B. K., Claude, L., Indelicato, D. J., & Laack, N. N. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28352 · Cited by 216 · see citing works
Bone tumors: osteosarcoma and Ewingʼs sarcoma
Heare, T., Hensley, M. A., & DellʼOrfano, S. (2009) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32832b1111 · Cited by 214 · see citing works
Sheng, G., Gao, Y., Yong, Y., & Wu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.780264 · Cited by 202 · see citing works
Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature
PosthumaDeBoer, J., Witlox, A. M. A., Kaspers, G. J. L., & van Royen, B. J. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9384-x · Cited by 192 · see citing works
Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
Angulo, P., Kaushik, G., Subramaniam, D., Dandawate, P. R., Neville, K. A., Chastain, K. M., & Anant, S. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0373-z · Cited by 186 · see citing works
Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma
Zhang, K., Dong, C., Chen, M., Yang, T.-T., Wang, X., Gao, Y., Wang, L., Wen, Y., Chen, G., Wang, X., et al. (2019) · Theranostics · doi:10.7150/thno.33482 · Cited by 172 · see citing works
Wang, D., Niu, X., Wang, Z., Song, C., Huang, Z., Chen, K., Duan, J., Bai, H., Xu, J., Zhao, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1086 · Cited by 148 · see citing works
Review of the Molecular Pathogenesis of Osteosarcoma
He, J., Hao, Y. X., Wang, X., Yang, X.-J., Shao, J., Guo, F.-J., & Feng, J. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.15.5967 · Cited by 128 · see citing works
Fujiwara, T., Uotani, K., Yoshida, A., Morita, T., Nezu, Y., Kobayashi, E., Yoshida, A., Uehara, T., Omori, T., Sugiu, K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16498 · Cited by 118 · see citing works
Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma
Evola, G., Costarella, L., Pavone, V., Caff, G., Cannavò, L., Sessa, A., Avondo, S., & Sessa, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00150 · Cited by 107 · see citing works
Odri, G. A., Tchicaya-Bouanga, J., Yoon, D. J. Y., & Modrowski, D. (2022) · Cancers · doi:10.3390/cancers14020360 · Cited by 104 · see citing works
Prognostic factors in pulmonary metastasized high‐grade osteosarcoma
Buddingh, E. P., Anninga, J., Versteegh, M. I. M., Taminiau, A. H. M., Egeler, R. M., van Rijswijk, C. S. P., Hogendoorn, P. C. W., Lankester, A. C., & Gelderblom, H. A. J. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22293 · Cited by 90 · see citing works
Wang, Y., Deng, X., Chang, Y., Zhao, G., Zhou, J., Zhang, G., Li, M., Jiang, D., Quan, Z., & Zhang, Y. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0922-0 · Cited by 86 · see citing works
International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines
Abib, S. D. C. V., Chui, C. H., Cox, S. G., Abdelhafeez, A. H., Fernández‐Pineda, I., Elgendy, A., Karpelowsky, J. S., Lobos, P. A., Wijnen, M., Fuchs, J., et al. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.1356 · Cited by 78 · see citing works
Wang, B., Su, Y., Yang, Q., Lv, D., Zhang, W., Tang, K., Wang, H., Zhang, R., & Liu, Y. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.2327 · Cited by 76 · see citing works
RetractedA Review of the Association between Osteosarcoma Metastasis and Protein Translation
Osborne, T. S., & Khanna, C. (2012) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2011.12.007 · Cited by 73 · see citing works
Fujiwara, T., Katsuda, T., Hagiwara, K., Kosaka, N., Yoshioka, Y., Takahashi, R., Takeshita, F., Kubota, D., Kondo, T., Ichikawa, H., et al. (2013) · Stem Cells · doi:10.1002/stem.1618 · Cited by 72 · see citing works
Palliative therapy for osteosarcoma
Errani, C., Longhi, A., Rossi, G., Rimondi, E., Biazzo, A., Toscano, A., Alì, N., Ruggieri, P., Alberghini, M., Picci, P., et al. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.172 · Cited by 71 · see citing works
Self-citationSurgical Intervention for Pulmonary Metastases
Pfannschmidt, J., Egerer, G., Bischof, M., Thomas, M., & Dienemann, H. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0645 · Cited by 70 · see citing works
Han, K., Zhao, T., Chen, X., Bian, N., Yang, T.-T., Ma, Q., Cai, C., Fan, Q., Zhou, Y., & Ma, B. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2571 · Cited by 68 · see citing works
Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma
Lu, K., Lu, P. W., Lu, E. W.-H., Lin, C., & Yang, S. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.80590 · Cited by 67 · see citing works
Quartuccio, N., Treglia, G., Salsano, M., Mattoli, M. V., Muoio, B., Piccardo, A., Lopci, E., & Cistaro, A. (2013) · Radiology and Oncology · doi:10.2478/raon-2013-0017 · Cited by 65 · see citing works
Zhao, Y., Tu, M., Yu, Y.-F., Wang, W.-P., Chen, Q., Qiu, J.-X., Yu, A.-X., & Yu, A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.10.015 · Cited by 64 · see citing works
Age-Period-Cohort Analysis of Primary Bone Cancer Incidence Rates in the United States (1976–2005)
Anfinsen, K. P., Devesa, S. S., Bray, F., Troisi, R. J., Jónasdóttir, T. J., Bruland, Ø. S., & Grotmol, T. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0136 · Cited by 63 · see citing works
Nugent, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-23730-5_11 · Cited by 60 · see citing works
High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients
Uzan, V. R. M., Lengert, A. V. H., Boldrini, É., Penna, V., Scapulatempo‐Neto, C., Scrideli, C. A., Filho, A. P. D. M., Cavalcante, C. E. B., de Oliveira, C. Z., Lopes, L. F., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156774 · Cited by 59 · see citing works
Current Treatment Considerations for Osteosarcoma Metastatic at Presentation
Tsukamoto, S., Errani, C., Angelini, A., & Mavrogenis, A. F. (2020) · Orthopedics · doi:10.3928/01477447-20200721-05 · Cited by 59 · see citing works
Treatment of Sarcoma Lung Metastases with Stereotactic Body Radiotherapy
Lindsay, A. D., Haupt, E. E., Chan, C. M., Spiguel, A., Scarborough, M. T., Zlotecki, R. A., & Gibbs, C. P. (2018) · Sarcoma · doi:10.1155/2018/9132359 · Cited by 57 · see citing works
Anfinsen, K. P., Grotmol, T., Bruland, Ø. S., & Jónasdóttir, T. J. (2011) · Europe PMC (PubMed Central) · Cited by 54 · see citing works
Zhang, F., Yan, T., Guo, W., Sun, K., Wang, S., Bao, X., Liu, K., Zheng, B., Zhang, H., & Ren, T. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0791-6 · Cited by 54 · see citing works
Williams, R. F., Fernández‐Pineda, I., & Gosain, A. (2016) · Surgical Clinics of North America · doi:10.1016/j.suc.2016.05.012 · Cited by 53 · see citing works
von Eisenhart‐Rothe, R., Toepfer, A. D. A., Salzmann, M., Schauwecker, J., Gollwitzer, H., & Rechl, H. (2011) · Der Orthopäde · doi:10.1007/s00132-011-1866-7 · Cited by 52 · see citing works
Redondo, A., Bagué, S., Bernabéu, D., Ortiz-Cruz, E. J., Valverde, C. M., Alvarez, R. M., Martínez‐Trufero, J., Lopez-Martin, J. A., Correa, R., Cruz, J., et al. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3436-0 · Cited by 52 · see citing works
Survival and prognostic factors following pulmonary metastasectomy for sarcoma
Marulli, G., Mammana, M., Comacchio, G. M., & Rea, F. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.03.177 · Cited by 51 · see citing works
Berner, K., Hall, K. S., Monge, O. R., Weedon‐Fekjær, H., Zaikova, O., & Bruland, Ø. S. (2015) · Sarcoma · doi:10.1155/2015/516843 · Cited by 48 · see citing works
Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma
Ren, Z., Liang, S., Yang, J., Han, X., Shan, L., Wang, B., Mu, T., Zhang, Y., Yang, X., Xiong, S., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4352-8 · Cited by 48 · see citing works
Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma
Negri, G. L., Grande, B. M., Delaidelli, A., El-Naggar, A. M., Cochrane, D. R., Lau, C. C., Triche, T. J., Moore, R. A., Jones, S. J. M., Montpetit, A., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5319 · Cited by 48 · see citing works
Khan, S., Ullah, M. W., Siddique, R., Liu, Y., Ullah, I., Xue, M., Yang, G., & Hou, H. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00499 · Cited by 47 · see citing works
TRIM59 is upregulated and promotes cell proliferation and migration in human osteosarcoma
Liang, J., Xing, D., Li, Z., Shen, J., Zhao, H., & Li, S. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5183 · Cited by 46 · see citing works
Zhao, Y., Tu, M., Wang, W.-P., Qiu, J.-X., Yu, A.-X., & Yu, A. (2016) · Scientific Reports · doi:10.1038/srep26611 · Cited by 44 · see citing works
Song, K., Song, J., Lin, K., Chen, F., Ma, X., Jiang, J., & Li, F. (2019) · International Orthopaedics · doi:10.1007/s00264-019-04348-4 · Cited by 42 · see citing works
Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells
Saini, H., Sharma, H., Mukherjee, S., Chowdhury, S., & Chowdhury, R. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01720-y · Cited by 42 · see citing works
Hedgehog Signaling Inhibitors as Anti-Cancer Agents in Osteosarcoma
Kumar, R. M. R., & Fuchs, B. (2015) · Cancers · doi:10.3390/cancers7020784 · Cited by 41 · see citing works
Tumor Suppressor WWOX inhibits osteosarcoma metastasis by modulating RUNX2 function
Mare, S. D., & Aqeilan, R. I. (2015) · Scientific Reports · doi:10.1038/srep12959 · Cited by 40 · see citing works
Fu, W., Noor, M. H. M., Yusof, L. M., Ibrahim, T. A. T., Yeap, S. K., Jaji, A. Z., & Zakaria, M. Z. A. B. (2017) · Journal of Experimental Nanoscience · doi:10.1080/17458080.2017.1287965 · Cited by 40 · see citing works
Targeting JNK-interacting protein 1 (JIP1) sensitises osteosarcoma to doxorubicin
PosthumaDeBoer, J., van Egmond, P. W., Helder, M. N., de Menezes, R. X., Cleton-Jansen, A., Beliën, J. A. M., Verheul, H. M. W., van Royen, B. J., Kaspers, G. J. L., & van Beusechem, V. W. (2012) · Oncotarget · doi:10.18632/oncotarget.600 · Cited by 39 · see citing works
den Hengst, W. A., Hendriks, J. M., Balduyck, B., Rodrigus, I. E. R., Vermorken, J. B., Lardon, F., Versteegh, M. I. M., Braun, J., Gelderblom, H. A. J., Schramel, F. M. N. H., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000279 · Cited by 39 · see citing works
He, T., Lin, X., Yang, C., Chen, Z., Wang, L., Li, Q., Ma, J., Zhan, F., Wang, Y., Jin, Y., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8966368 · Cited by 38 · see citing works
The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence
Angelini, A., Ceci, F., Castellucci, P., Graziani, T., Polverari, G., Trovarelli, G., Palmerini, E., Ferrari, S. M., Fanti, S., & Ruggieri, P. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3698-0 · Cited by 38 · see citing works
Self-citationWang, F., Ke, Z., Wang, R., Wang, Y., Huang, L.-L., & Wang, L. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.009 · Cited by 37 · see citing works
Loh, A. H. P., Stewart, E., Bradley, C. L., Chen, X., Daryani, V., Stewart, C. F., Calabrese, C., Funk, A., Miller, G., Karlstrom, A., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2018.10.033 · Cited by 36 · see citing works
Tomonaga, M. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1209 · Cited by 35 · see citing works
Canine osteosarcoma in comparative oncology: Molecular mechanisms through to treatment discovery
Simpson, S., Rizvanov, A. A., Jeyapalan, J. N., de Brot, S., & Rutland, C. S. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.965391 · Cited by 34 · see citing works
Li, P.-C., Tu, M., Ho, P. Y., Batra, N., Tran, M., Qiu, J.-X., Wun, T., Lara, P. N., Hu, X., Yu, A.-X., et al. (2021) · Theranostics · doi:10.7150/thno.56596 · Cited by 34 · see citing works
Mukherjee, S., Dash, S., Lohitesh, K., & Chowdhury, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179203 · Cited by 34 · see citing works
Chen, Y., Sun, J., Huang, Y., Liu, Y., Liang, L., Yang, D., Lu, B., & Li, S. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.09.005 · Cited by 32 · see citing works
The Effect of Cold Atmospheric Plasma on the Membrane Permeability of Human Osteosarcoma Cells
Haralambiev, L., Nitsch, A., Einenkel, R., Muzzio, D. O., Gelbrich, N., Burchardt, M., Zygmunt, M., Ekkernkamp, A., Stope, M. B., & Gümbel, D. (2020) · Anticancer Research · doi:10.21873/anticanres.14016 · Cited by 31 · see citing works
miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells
Wang, J., Wang, B., Chen, L., Yang, J., Gong, Z., Zhao, X., Zhang, C., & Du, K. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.09.108 · Cited by 30 · see citing works
Hasan, H., Deek, M. P., Phillips, R., Hobbs, R. F., Malek, R. A., Radwan, N., Kiess, A. P., Dipasquale, S., Huang, J. G., Caldwell, T. G., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-07000-2 · Cited by 30 · see citing works
RhoA enhances osteosarcoma resistance to MPPa-PDT via the Hippo/YAP signaling pathway
Zhan, F., He, T., Chen, Z., Zuo, Q., Wang, Y., Li, Q., Zhong, S., & Ou, Y. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00690-6 · Cited by 29 · see citing works
Denosumab does not decrease the risk of lung metastases from bone giant cell tumour
Tsukamoto, S., Mavrogenis, A. F., Leone, G., Righi, A., Akahane, M., Tanzi, P., Kido, A., Honoki, K., Tanaka, Y., Donati, D. M., et al. (2018) · International Orthopaedics · doi:10.1007/s00264-018-4085-6 · Cited by 28 · see citing works
A deep belief network-based clinical decision system for patients with osteosarcoma
Li, W., Dong, Y., Liu, W., Tang, Z., Sun, C., Lowe, S., Chen, S., Bentley, R., Zhou, Q., Xu, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1003347 · Cited by 28 · see citing works
Second primary osteosarcomas in patients with retinoblastoma
Fujiwara, T., Fujiwara, M., Numoto, K., Ogura, K., Yoshida, A., Yonemoto, T., Suzuki, S., & Kawai, A. (2015) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv140 · Cited by 28 · see citing works
Fujiwara, T., Rincon, M. R. M., Sambri, A., Tsuda, Y., Balko, J., Sumathi, V. P., Gregory, J., Jeys, L. M., & Abudu, A. (2019) · The Bone & Joint Journal · doi:10.1302/0301-620x.101b8.bjj-2018-0963.r1 · Cited by 28 · see citing works
TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma
Qin, Y., Ye, J., Zhao, F., Hu, S., & Wang, S. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4494 · Cited by 27 · see citing works
RPN2 Gene Confers Osteosarcoma Cell Malignant Phenotypes and Determines Clinical Prognosis
Fujiwara, T., Takahashi, R., Kosaka, N., Nezu, Y., Kawai, A., Ozaki, T., & Ochiya, T. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.35 · Cited by 26 · see citing works
Wang, S., Ren, T., Huang, Y., Bao, X., Sun, K., Shen, D., & Guo, W. (2017) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2017.05.09 · Cited by 26 · see citing works
Ali, B. A., Salman, M., Ghanem, K. M., Boulos, F. I., Haidar, R., Saghieh, S., Akel, S. R., Muwakkit, S. A., El‐Solh, H., Saab, R. H., et al. (2019) · Journal of Global Oncology · doi:10.1200/jgo.17.00241 · Cited by 26 · see citing works
Li, Z., Wang, L., Luo, N., Zhao, Y., Li, J., Chen, Q., & Tian, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.8297 · Cited by 25 · see citing works
Malik, A. T., Alexander, J. H., Mayerson, J. L., Khan, S. N., & Scharschmidt, T. J. (2020) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000001361 · Cited by 25 · see citing works
Palliative embolization for osteosarcoma
Mavrogenis, A. F., Rossi, G., Rimondi, E., Calabrò, T., Papagelopoulos, P. J., & Ruggieri, P. (2013) · European Journal of Orthopaedic Surgery & Traumatology · doi:10.1007/s00590-013-1312-0 · Cited by 24 · see citing works
Advanced development of ErbB family-targeted therapies in osteosarcoma treatment
Wang, W., Zhao, H., Yao, T.-F., & Gong, H. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0684-8 · Cited by 24 · see citing works
Tspan9 Induces EMT and Promotes Osteosarcoma Metastasis via Activating FAK-Ras-ERK1/2 Pathway
Shao, S., Piao, L., Wang, J., Guo, L., Wang, J., Wang, L., Tong, L., Yuan, X., Han, X., Fang, S., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.774988 · Cited by 23 · see citing works
Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents
Meazza, C., Luksch, R., Daolio, P. A., Podda, M. G., Luzzati, A., Gronchi, A., Parafioriti, A., Gandola, L., Collini, P., Ferrari, A., et al. (2014) · Medical Oncology · doi:10.1007/s12032-014-0875-x · Cited by 23 · see citing works
Role of miR‐142 in the pathogenesis of osteosarcoma and its potential as therapeutic approach
Shabani, P., Izadpanah, S., Aghebati‐Maleki, A., Baghbani, E., Baghbanzadeh, A., Fotouhi, A., Bakhshinejad, B., Maleki, L. A., & Baradaran, B. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27857 · Cited by 23 · see citing works
Mechanisms of therapy resistance in osteosarcoma: a review
PosthumaDeBoer, J., van Royen, B. J., & Helder, M. N. (2013) · Oncology Discovery · doi:10.7243/2052-6199-1-8 · Cited by 22 · see citing works
Wang, X., Du, J., Gu, P., Jin, R., & Lin, X. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2110 · Cited by 21 · see citing works
SEOM clinical guidelines for the treatment of osteosarcoma in adults-2013
Redondo, A., Cruz, J. J., Pousa, A. L., & Barón, F. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1087-0 · Cited by 21 · see citing works
Polydatin enhances the chemosensitivity of osteosarcoma cells to paclitaxel
Zhao, W., Chen, Z., & Guan, M. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29012 · Cited by 20 · see citing works
Osteosarcoma of the Pelvis: A Monoinstitutional Experience in Patients Younger than 41 Years
Ferrari, S., Palmerini, E., Fabbri, N., Staals, E. L., Ferrari, C., Alberghini, M., & Picci, P. (2012) · Tumori Journal · doi:10.1177/030089161209800605 · Cited by 19 · see citing works
Self-citationIMPDH2 mediate radioresistance and chemoresistance in osteosarcoma cells.
Hx, L., Qp, M., Liu, W. T., Yg, L., Hm, Z., Fc, B., Song, L.-L., & Hj, L. (2014) · PubMed · Cited by 19 · see citing works
FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome
Huang, Z., Li, J., Du, S., Tang, Y., Huang, L., Xiao, L., & Tong, P. (2016) · Oncotarget · doi:10.18632/oncotarget.9524 · Cited by 19 · see citing works
RetractedBasile, P., Greengard, E. G., Weigel, B. J., & Spector, L. G. (2020) · Sarcoma · doi:10.1155/2020/7431549 · Cited by 18 · see citing works
The metastatic behavior of osteosarcoma by gene expression and cytogenetic analyses
Salinas-Souza, C., de Oliveira, R., Alves, M. T. D. S., Jesús-García, R., Petrilli, A. S., & de Toledo, S. R. C. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.04.013 · Cited by 17 · see citing works
Matsuda, K., Miyoshi, H., Hiraoka, K., Hamada, T., Nakashima, K., Shiba, N. N., & Ohshima, K. (2018) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000000379 · Cited by 16 · see citing works
A Preliminary Evaluation of Limb Salvage Surgery for Osteosarcoma around Knee Joint
Wu, X., Cai, Z.-D., Chen, Z., Yao, Z., & Zhang, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033492 · Cited by 16 · see citing works
Dai, X., Ma, W., He, X., & Jha, R. K. (2012) · Medical Oncology · doi:10.1007/s12032-012-0347-0 · Cited by 16 · see citing works
Takenaka, S., Tamiya, H., Wakamatsu, T., Nakai, S., Imura, Y., Outani, H., Yagi, T., & Kawai, A. (2021) · Cancers · doi:10.3390/cancers13133320 · Cited by 15 · see citing works
Du, L., Zhu, G., Xu, Y., Han, B., Wang, Y., Zhu, M., Meng, Y., Chen, H., & Yu, Z. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1147064 · Cited by 15 · see citing works
Chen, Z., Gao, P., & Li, Z. (2016) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.239.203 · Cited by 15 · see citing works
Caldarella, C., Salsano, M., Isgrò, M. A., & Treglia, G. (2012) · International Journal of Molecular Imaging · doi:10.1155/2012/870301 · Cited by 14 · see citing works
Schuster, A. J., Kager, L., Reichardt, P., Baumhoer, D., Csóka, M., Hecker‐Nolting, S., Lang, S., Lorenzen, S., Mayer‐Steinacker, R., Kalle, T. V., et al. (2018) · Sarcoma · doi:10.1155/2018/1632978 · Cited by 14 · see citing works
- Authors
- Bacci, G., Rocca, M., Salone, M., Balladelli, A., Ferrari, S., Palmerini, E., Forni, C., & Briccoli, A.
- Affiliations
- Istituto Ortopedico Rizzoli (IT)
- Corresponding author
- Bacci, Gaetano
- Venue
- Journal of Surgical Oncology
- Publisher
- Wiley
- Published
- 2008-09-15
- Volume
- 98
- Issue
- 6
- Pages
- 415-420
- ISSN
- 0022-4790 (ISSN-L)
- 1096-9098
- OpenAlex
- W2072874660
- Cited by
- 203
- References
- 20
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 15 · 2023: 13 · 2022: 13 · 2021: 18 · 2020: 10 · 2019: 14 · 2018: 15 · 2017: 12 · 2016: 13 · 2015: 12 · 2014: 10 · 2013: 11 · 2012: 13
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Surgical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoma Diagnosis and Treatment
- Health Sciences › Medicine › Rheumatology › Bone Tumor Diagnosis and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac tumors and thrombi
- Keywords
- high-grade osteosarcoma, extremity osteosarcoma, lung metastasis, neoadjuvant chemotherapy, simultaneous resection, metastasectomy, event-free survival, prognostic factors
- MeSH terms
- Adolescent, Adult, Amputation, Surgical, Antineoplastic Agents, Bone Neoplasms, Child, Diagnostic Imaging, Extremities, Female, Humans, Lung Neoplasms, Lymphatic Metastasis, Male, Middle Aged, Pneumonectomy, Retrospective Studies, Osteosarcoma, Disease-Free Survival, Neoadjuvant Therapy, Limb Salvage
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
